Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VT103 |
Trade Name | |
Synonyms | VT-103|VT 103 |
Drug Descriptions |
VT103 selectively inhibits TEAD1 palmitoylation, which results in decreased YAP/TAZ signaling and potentially reduces tumor growth (PMID: 33850002). |
DrugClasses | |
CAS Registry Number | 2290608-13-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Defactinib + VT103 | Defactinib VT103 | 0 | 0 |
VT103 | VT103 | 0 | 0 |